DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vinblastine (Vinblastine) - Hypoaesthesia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hypoaesthesia (2)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vinblastine where reactions include hypoaesthesia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Vinblastine side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-11

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Gait Disturbance, Coordination Abnormal, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin Sulfate
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 45 mg/m2, unk

Cisplatin
    Dosage: 90 mg/m2, over 4h on day1
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m2, unk

Cyclophosphamide
    Dosage: 1000 mg/m2, over 60min on day 2
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m2, unk

Doxorubicin HCL
    Dosage: 45 mg/m2, over 30min on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 200 mg/m2, over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m2, unk

Vinblastine
    Dosage: 6 mg/m2, over 30 minutes on day 1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim



Possible Vinblastine side effects in 28 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-06-29

Patient: 28 year old female

Reactions: Streptococcal Bacteraemia, Vomiting, Nausea, Peripheral Sensorimotor Neuropathy, Carbon Monoxide Diffusing Capacity Decreased, Pancytopenia, Febrile Neutropenia, Hypoaesthesia, Paraesthesia, Coordination Abnormal, Gait Disturbance, Renal Failure Acute

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Bleomycin
    Dosage: 15 units/m2 over 24h on day2

Cisplatin
    Dosage: 90 mg/m2 over 4h on day1
    Indication: Ovarian Cancer

Cisplatin
    Dosage: 45 mg/m 2

Cyclophosphamide
    Dosage: 1000 mg/m2 over 60min on day 2
    Indication: Ovarian Cancer

Cyclophosphamide
    Dosage: 750 mg/m 2

Doxorubicin HCL
    Dosage: 45 mg/m2 over 30min on day3
    Indication: Ovarian Cancer

Doxorubicin HCL
    Dosage: 30 mg/m 2

Etoposide
    Dosage: 200 mg/m2 over 2h on day3
    Indication: Ovarian Cancer

Etoposide
    Dosage: 100 mg/m 2

Vinblastine
    Dosage: 6mg/m2 over 30min on day1
    Indication: Ovarian Cancer

Other drugs received by patient: Pegfilgrastim

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017